| Primary |
| Birth Control |
60.0% |
| Contraception |
20.0% |
| Uterine Haemorrhage |
20.0% |
|
| Pulmonary Embolism |
50.0% |
| Headache |
25.0% |
| Pyrexia |
25.0% |
|
| Secondary |
| Contraception |
26.8% |
| Hormone Replacement Therapy |
22.0% |
| Prophylaxis |
19.5% |
| Product Used For Unknown Indication |
7.3% |
| Migraine |
4.9% |
| Bipolar Disorder |
2.4% |
| Menopause |
2.4% |
| Menorrhagia |
2.4% |
| Menstruation Irregular |
2.4% |
| Oral Contraception |
2.4% |
| Post Coital Contraception |
2.4% |
| Psoriasis |
2.4% |
| Weight Control |
2.4% |
|
| Metrorrhagia |
15.4% |
| Off Label Use |
15.4% |
| Breast Cancer Female |
7.7% |
| Breast Cancer Metastatic |
7.7% |
| Deafness Unilateral |
7.7% |
| Insomnia |
7.7% |
| Menstruation Irregular |
7.7% |
| Sleep Disorder |
7.7% |
| Swelling Face |
7.7% |
| Vomiting |
7.7% |
| Wound Infection |
7.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
30.6% |
| Contraception |
15.4% |
| Acne |
6.9% |
| Pain |
4.2% |
| Rheumatoid Arthritis |
4.2% |
| Anxiety |
4.0% |
| Multiple Sclerosis |
4.0% |
| Crohn's Disease |
3.8% |
| Migraine |
3.8% |
| Depression |
3.3% |
| Psoriasis |
3.1% |
| Asthma |
2.9% |
| Diabetes Mellitus |
2.2% |
| Insomnia |
2.2% |
| Attention Deficit/hyperactivity Disorder |
1.6% |
| Endometriosis |
1.6% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Sleep Disorder |
1.6% |
| Vitamin Supplementation |
1.6% |
| Bipolar Disorder |
1.3% |
|
| Vomiting |
12.4% |
| White Blood Cell Count Decreased |
9.5% |
| Osteopenia |
8.6% |
| Pain |
8.6% |
| Drug Ineffective |
5.7% |
| Nausea |
5.7% |
| Migraine |
4.8% |
| Pulmonary Embolism |
4.8% |
| Upper Respiratory Tract Infection |
4.8% |
| Off Label Use |
3.8% |
| Talipes |
3.8% |
| Therapeutic Response Decreased |
3.8% |
| Thrombophlebitis Superficial |
3.8% |
| Blood Growth Hormone Abnormal |
2.9% |
| Bradycardia |
2.9% |
| Fatigue |
2.9% |
| Palpitations |
2.9% |
| Pruritus |
2.9% |
| Transverse Sinus Thrombosis |
2.9% |
| Weight Increased |
2.9% |
|
| Interacting |
| Contraception |
50.0% |
| Blood Cholesterol Increased |
25.0% |
| Product Used For Unknown Indication |
25.0% |
|
| Vaginal Haemorrhage |
50.0% |
| Wrong Technique In Drug Usage Process |
50.0% |
|
